Intelligent Bio Solutions (INBS) EBIAT (2019 - 2024)
Intelligent Bio Solutions has reported EBIAT over the past 6 years, most recently at -$3.0 million for Q1 2024.
- Quarterly results put EBIAT at -$3.0 million for Q1 2024, up 53.06% from a year ago — trailing twelve months through Mar 2024 was -$10.0 million (changed 0.0% YoY), and the annual figure for FY2024 was -$10.2 million, up 4.15%.
- EBIAT for Q1 2024 was -$3.0 million at Intelligent Bio Solutions, down from -$2.0 million in the prior quarter.
- Over the last five years, EBIAT for INBS hit a ceiling of -$111107.0 in Q1 2020 and a floor of -$6.3 million in Q1 2023.
- Median EBIAT over the past 5 years was -$2.0 million (2023), compared with a mean of -$2.1 million.
- Biggest five-year swings in EBIAT: crashed 2715.14% in 2021 and later soared 87.67% in 2022.
- Intelligent Bio Solutions' EBIAT stood at -$2.0 million in 2020, then tumbled by 74.03% to -$3.5 million in 2021, then soared by 87.67% to -$427071.0 in 2022, then crashed by 362.78% to -$2.0 million in 2023, then plummeted by 50.66% to -$3.0 million in 2024.
- The last three reported values for EBIAT were -$3.0 million (Q1 2024), -$2.0 million (Q4 2023), and -$2.4 million (Q3 2023) per Business Quant data.